Engaging Academia, Community Investigators, and Other Important Stakeholders to Generate Influential Real World Evidence that Improves Patient Care

Watch On Demand!

How can we generate real world data (RWD) and real world evidence (RWE) by bringing together academia, industry, regulatory authorities, and patient advocacy representatives?

Collaboration leads to joint real-world studies, publications, and meeting presentations that better inform the medical community
Collaboration with academia, community investigators, pharma, and patient advocacy communities requires special considerations and approaches
Collaboration with regulatory stakeholders leads to alignment with dynamic and continuously evolving RWE framework and guidelines
In doing so, analytics and outputs can remain at the forefront of new RWE expectations and requirements
Process of creating RWE disease communities, partnerships with stakeholders, and tying advanced analytics from a variety of datasets to report on the RWD

Featured Topics include:

Why collaborate in the first place?
Considering needs and goals of industry partners and stakeholder identification
Building academic/community collaboration and partnerships
Including regulatory stakeholders in the collaboration process
Listening to the patient advocacy community
Bringing all stakeholders together with the end goal of generating meaningful real-world evidence that can improve patient care

Please note that this is an exhibitor sponsored event and is not eligible for CE credit.

Presenter:

			Michael W. Fried, MD, FAASLD, Co-Founder and Chief Medical Officer, Target RWE

Email Address:

First Name:

Last Name:

Job Title:

Company Name:

Phone Number:

Country:

State:

By registering for this Solution Provider Session, I share my full contact information with the Solution Provider. I understand that the Solution Provider may contact me with messages asking me to consider use of their products or services:

Watch On Demand!

Section 3 Headline

Section 3 Point 1

Section 3 Point 2

Section 3 Point 3

Section 4 - Point 1

Section 4 - Point 2

Section 4 - Point 3

Section 5 Title

Section 6 Title

Section 7 Video Title